Helping our patient communities and advancing knowledge in our therapy areas is part of our corporate responsibility.
It is our mission to discover, develop, and deliver innovative therapies that improve patients' quality of life.
We work with government authorities to ensure patients have access to care while also funding medical research.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
Every day at CSL Behring, we work as if someone’s life depends on it, because it does.
CSL Behring biotherapies are manufactured in state-of-the-art facilities under stringent, controlled conditions.
Help us deliver on our promise to save lives and protect the health of people.
Make your well-being a priority. It's important and so are you.
HAE International’s emergency cards help physicians provide the right care in critical moments.
Our patients share what it’s like to be a parent living with a rare condition.
Biotech CSL Behring unveils expansion plans in Marburg.
Replacing C1-INH plasma protein gives a rare disease a longed-for treatment.
One mom's tips for ensuring a child's condition is managed in the classroom.
We asked patients for advice on managing their rare disease while traveling.
Patients on why having a rare condition is only part of their lives.
Following the “Camino” in Spain, walkers will raise awareness about hereditary angioedema.
Director and HAE patient Natalie Metzger on putting faces to the rare disease.
Patient advocates share stories to empower others living with similar conditions.
For some patients, rhythm and beats can complement hospitals and medication.
See Machelle’s Promising Tips for helping a child be their own rare disease advocate.
Popular search terms:
Americas
Asia Pacific
Europe
